April 12 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® PRESENTS PRECLINICAL DATA ON PELAREOREP-BASED COMBINATION THERAPIES AT AACR ANNUAL MEETING
* ONCOLYTICS BIOTECH INC - PELAREOREP SYNERGIZES WITH A BROAD ARRAY OF ANTI-CANCER AGENTS
* ONCOLYTICS BIOTECH INC - PELAREOREP ENHANCES ANTI-TUMOR EFFICACY OF PARP-1 AND CDK 4/6 INHIBITORS IN PRECLINICAL MODELS